Sudden sensorineural hearing loss strikes without warning, and identifying its modifiable risk factors could meaningfully change how clinicians counsel patients with metabolic conditions. A critical gap has persisted in the literature: while observational data suggested metabolic disorders raise SSNHL risk, confounding and reverse causation made it impossible to confirm true causality — until now.
Using bidirectional and multivariable Mendelian randomization — a method that leverages inherited genetic variants as natural randomization tools to approximate causal inference — researchers analyzed genome-wide association study data to test whether type 2 diabetes, type 1 diabetes, obesity, and hyperlipidemia independently drive SSNHL risk. The inverse variance weighted analysis found that type 2 diabetes (T2D) carries a statistically significant causal effect on SSNHL risk, with an odds ratio of 1.18 (95% CI: 1.02–1.36). Crucially, this association held after adjusting for obesity and hyperlipidemia in the multivariable model (OR 1.17), isolating T2D as an independent contributor. No causal signal emerged for type 1 diabetes, obesity, or lipid disorders acting alone.
This finding is clinically meaningful for several reasons. Mendelian randomization's strength lies in its resistance to lifestyle confounders that plague conventional epidemiology — here, the causal direction runs from T2D toward hearing loss, not the reverse. The proposed mechanism is plausible: chronic hyperglycemia damages the cochlear microvasculature and stria vascularis through oxidative stress and advanced glycation end-products, mirroring diabetic microvascular injury elsewhere. What's notable is the clean separation between T2D and T1D effects, suggesting hyperinsulinemia or insulin resistance pathways — rather than hyperglycemia alone — may be the operative mechanism. Key limitations include reliance on summary-level GWAS data, predominantly European ancestry samples limiting generalizability, and the inherent inability of MR to fully exclude all pleiotropic pathways. For health-conscious adults, this study reinforces that T2D management is not just cardiovascular protection — it may also preserve auditory function into later life.